Not long ago, a medical device was generally considered “done” when it reached the market. While the product pipeline might have included incremental updates, the device already on the market was basically fixed in terms of its safety, effectiveness and value. Today, that approach to the medical device lifecycle is fast becoming retro. Orthopedic companies that incorporate software, connectivity and artificial intelligence into their products will be able to enhance their devices and outpace their competition.

Join this discussion to explore how and why software and AI will advance in orthopedics and the steps product development, regulatory and quality professionals should take today to stay ahead of the curve. Attendees will take away the following lessons: a framework for thinking about the value that AI can bring to medical devices; examples of case studies illustrating that value; one or two questions to ask about your firm’s device pipeline and how AI-enable might (or might not) have a role to play in it.